CRONOS GROUP INC. Deferred Income Tax Expense (Benefit)
CRONOS GROUP INC. (CRON) reported Deferred Income Tax Expense (Benefit) of $1.13 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-02-26
- CRONOS GROUP INC. deferred income tax expense (benefit) for fiscal 2025 was $1.13M.
- CRONOS GROUP INC. deferred income tax expense (benefit) for fiscal 2024 was -$266.00K, a 283.45% decline from fiscal 2023.
- CRONOS GROUP INC. deferred income tax expense (benefit) for fiscal 2023 was $145.00K.
- CRONOS GROUP INC. deferred income tax expense (benefit) for fiscal 2022 was -$241.00K, a 702.50% decline from fiscal 2021.
| Period end | Deferred Income Tax Expense (Benefit) 12 month |
|---|---|
| 2025-12-31 | $1.13M 10-K · filed 2026-02-26 |
| 2024-12-31 | -$266.00K 10-K · filed 2026-02-26 |
| 2023-12-31 | $145.00K 10-K · filed 2026-02-26 |
| 2022-12-31 | -$241.00K 10-K · filed 2025-02-27 |
| 2021-12-31 | $40.00K 10-K · filed 2024-02-29 |
| 2020-12-31 | $0.00 10-K · filed 2023-02-28 |
| 2019-12-31 | $0.00 10-K · filed 2022-03-01 |
| 2018-12-31 | $0.00 10-K · filed 2021-02-26 |
| 2017-12-31 | $0.00 10-K/A · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |